BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37610426)

  • 21. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.
    Dong J; Buas MF; Gharahkhani P; Kendall BJ; Onstad L; Zhao S; Anderson LA; Wu AH; Ye W; Bird NC; Bernstein L; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; Iyer PG; Reid BJ; Hardie LJ; Lagergren J; Shaheen NJ; Corley DA; Fitzgerald RC; ; Whiteman DC; Vaughan TL; Thrift AP
    Gastroenterology; 2018 Apr; 154(5):1273-1281.e3. PubMed ID: 29247777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychosocial moderation of polygenic risk for cannabis involvement: the role of trauma exposure and frequency of religious service attendance.
    Meyers JL; Salvatore JE; Aliev F; Johnson EC; McCutcheon VV; Su J; Kuo SI; Lai D; Wetherill L; Wang JC; Chan G; Hesselbrock V; Foroud T; Bucholz KK; Edenberg HJ; Dick DM; Porjesz B; Agrawal A
    Transl Psychiatry; 2019 Oct; 9(1):269. PubMed ID: 31636251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validating and automating learning of cardiometabolic polygenic risk scores from direct-to-consumer genetic and phenotypic data: implications for scaling precision health research.
    Lopez-Pineda A; Vernekar M; Moreno-Grau S; Rojas-Muñoz A; Moatamed B; Lee MTM; Nava-Aguilar MA; Gonzalez-Arroyo G; Numakura K; Matsuda Y; Ioannidis A; Katsanis N; Takano T; Bustamante CD
    Hum Genomics; 2022 Sep; 16(1):37. PubMed ID: 36076307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model.
    Hung RJ; Warkentin MT; Brhane Y; Chatterjee N; Christiani DC; Landi MT; Caporaso NE; Liu G; Johansson M; Albanes D; Marchand LL; Tardon A; Rennert G; Bojesen SE; Chen C; Field JK; Kiemeney LA; Lazarus P; Zienolddiny S; Lam S; Andrew AS; Arnold SM; Aldrich MC; Bickeböller H; Risch A; Schabath MB; McKay JD; Brennan P; Amos CI
    Cancer Res; 2021 Mar; 81(6):1607-1615. PubMed ID: 33472890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current State and Future of Polygenic Risk Scores in Cardiometabolic Disease: A Scoping Review.
    Phulka JS; Ashraf M; Bajwa BK; Pare G; Laksman Z
    Circ Genom Precis Med; 2023 Jun; 16(3):286-313. PubMed ID: 37035923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial and autophagy-lysosomal pathway polygenic risk scores predict Parkinson's disease.
    Dehestani M; Liu H; Sreelatha AAK; Schulte C; Bansal V; Gasser T
    Mol Cell Neurosci; 2022 Jul; 121():103751. PubMed ID: 35710056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry.
    Pal Choudhury P; Brook MN; Hurson AN; Lee A; Mulder CV; Coulson P; Schoemaker MJ; Jones ME; Swerdlow AJ; Chatterjee N; Antoniou AC; Garcia-Closas M
    Breast Cancer Res; 2021 Feb; 23(1):22. PubMed ID: 33588869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of optimal methods and ancestries for calculating polygenic risk scores in East Asian population.
    Kim DJ; Kang JH; Kim JW; Cheon MJ; Kim SB; Lee YK; Lee BC
    Sci Rep; 2023 Nov; 13(1):19195. PubMed ID: 37932343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pitfalls of predicting age-related traits by polygenic risk scores.
    Escott-Price V; Schmidt KM
    Ann Hum Genet; 2023 Sep; 87(5):203-209. PubMed ID: 37416935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Polygenic Risk Score in the Familial Transmission of Bipolar Disorder in Youth.
    Birmaher B; Hafeman D; Merranko J; Zwicker A; Goldstein B; Goldstein T; Axelson D; Monk K; Hickey MB; Sakolsky D; Iyengar S; Diler R; Nimgaonkar V; Uher R
    JAMA Psychiatry; 2022 Feb; 79(2):160-168. PubMed ID: 34935868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polygenic Scores for Height in Admixed Populations.
    Bitarello BD; Mathieson I
    G3 (Bethesda); 2020 Nov; 10(11):4027-4036. PubMed ID: 32878958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans.
    Shams H; Shao X; Santaniello A; Kirkish G; Harroud A; Ma Q; Isobe N; ; Schaefer CA; McCauley JL; Cree BAC; Didonna A; Baranzini SE; Patsopoulos NA; Hauser SL; Barcellos LF; Henry RG; Oksenberg JR
    Brain; 2023 Feb; 146(2):645-656. PubMed ID: 35253861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polygenic risk scores: from research tools to clinical instruments.
    Lewis CM; Vassos E
    Genome Med; 2020 May; 12(1):44. PubMed ID: 32423490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pragmatic Approach to Applying Polygenic Risk Scores to Diverse Populations.
    Patel AP; Fahed AC
    Curr Protoc; 2023 Nov; 3(11):e911. PubMed ID: 37921506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On cross-ancestry cancer polygenic risk scores.
    Fritsche LG; Ma Y; Zhang D; Salvatore M; Lee S; Zhou X; Mukherjee B
    PLoS Genet; 2021 Sep; 17(9):e1009670. PubMed ID: 34529658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction.
    Galeotti AA; Gentiluomo M; Rizzato C; Obazee O; Neoptolemos JP; Pasquali C; Nentwich M; Cavestro GM; Pezzilli R; Greenhalf W; Holleczek B; Schroeder C; Schöttker B; Ivanauskas A; Ginocchi L; Key TJ; Hegyi P; Archibugi L; Darvasi E; Basso D; Sperti C; Bijlsma MF; Palmieri O; Hlavac V; Talar-Wojnarowska R; Mohelnikova-Duchonova B; Hackert T; Vashist Y; Strouhal O; van Laarhoven H; Tavano F; Lovecek M; Dervenis C; Izbéki F; Padoan A; Małecka-Panas E; Maiello E; Vanella G; Capurso G; Izbicki JR; Theodoropoulos GE; Jamroziak K; Katzke V; Kaaks R; Mambrini A; Papanikolaou IS; Szmola R; Szentesi A; Kupcinskas J; Bursi S; Costello E; Boggi U; Milanetto AC; Landi S; Gazouli M; Vodickova L; Soucek P; Gioffreda D; Gemignani F; Brenner H; Strobel O; Büchler M; Vodicka P; Paiella S; Canzian F; Campa D
    J Med Genet; 2021 Jun; 58(6):369-377. PubMed ID: 32591343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic liability for substance use associated with medical comorbidities in electronic health records of African- and European-ancestry individuals.
    Hartwell EE; Merikangas AK; Verma SS; Ritchie MD; ; Kranzler HR; Kember RL
    Addict Biol; 2022 Jan; 27(1):e13099. PubMed ID: 34611967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving polygenic prediction in ancestrally diverse populations.
    Ruan Y; Lin YF; Feng YA; Chen CY; Lam M; Guo Z; ; He L; Sawa A; Martin AR; Qin S; Huang H; Ge T
    Nat Genet; 2022 May; 54(5):573-580. PubMed ID: 35513724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer.
    Plym A; Penney KL; Kalia S; Kraft P; Conti DV; Haiman C; Mucci LA; Kibel AS
    J Natl Cancer Inst; 2022 May; 114(5):771-774. PubMed ID: 33792693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk.
    Perkins DO; Olde Loohuis L; Barbee J; Ford J; Jeffries CD; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; McGlashan TH; Seidman LJ; Tsuang M; Walker EF; Woods SW
    Am J Psychiatry; 2020 Feb; 177(2):155-163. PubMed ID: 31711302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.